Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

BioSante to Use Cell Genesys Cash for Sex-Gel Trials
Bloomberg
Monday, August 10, 2009 - 10:00am
tags:
BioSante, Cell Genesys, sexual dysfunction
MedImmune Advances Three Oncology Programs into Clinical Development
Yahoo
Monday, August 10, 2009 - 9:59am
tags:
MedImmune, drug trials, oncology, cancer
Japan's Daiichi Sankyo says new flu drug effective
Google/AFP
Monday, August 10, 2009 - 9:57am
tags:
Daiichi Sankyo, Japan, Flu, Tamiflu
Oxford researchers on swine flu: 'Tamiflu harm outweighs benefits for children'
Telegraph, UK
Monday, August 10, 2009 - 9:53am
tags:
swine flu, H1N1, Tamiflu, Roche, GSK
Forest Laboratories signs deal to sell Nycomed's chronic bronchitis drug Daxas in US
Yahoo/AP
Monday, August 10, 2009 - 9:50am
tags:
bronchitis, Forest Labs, Nycomed, partnerships, Daxas
Drugmakers’ Deal Doesn’t Bind Congress in Health-Care Debate
Bloomberg
Monday, August 10, 2009 - 9:49am
tags:
healthcare reform
Merck Faces First Trial of Claim That Fosamax Attacks Jawbone
Bloomberg
Monday, August 10, 2009 - 9:48am
tags:
Merck, Fosamax, osteoporosis
Lilly leads drug stocks south
Marketwatch
Monday, August 10, 2009 - 9:46am
tags:
Eli Lilly, drug stocks
Spotlight on Biotech: 10 Promising Companies
Seeking Alpha
Sunday, August 9, 2009 - 11:57am
tags:
biotech, Biogen Idec, Covance, Forest Labs, Genzyme, Myriad Genetics, Novo Nordisk, Techne, PPDI, Teva Pharmaceuticals, Warner Chilcott
Pharma Cash for Clunkers
InVivo
Sunday, August 9, 2009 - 11:52am
tags:
JNJ, Elan, Biogen Idec, Anesiva, Arcion Therapeutics, GSK, Vernalis, Purdue, Transcept, NicOx, Pfizer
How will Cephalon shift patients to Nuvigil?
Fierce Pharma
Sunday, August 9, 2009 - 11:50am
tags:
Cephalon, NUVIGIL, generics
Biotech Discounts Galore
Seeking Alpha
Sunday, August 9, 2009 - 11:48am
tags:
biotech, RXi Pharmaceuticals, Ariad Pharmaceuticals, Human Genome Sciences, Inspire, MannKind, MAP Pharmaceuticals, Opexa, Transcept, Anesiva, Indenix
Emergent BioSolutions: Little Risk, Potentially Huge Reward
Seeking Alpha
Sunday, August 9, 2009 - 11:46am
tags:
Emergent BioSolutions, BioThrax
More Swine Flu Shots May Beat Treatment in U.K., Lancet Says
Bloomberg
Saturday, August 8, 2009 - 12:36pm
tags:
UK, vaccines, swine flu, H1N1
Drugmakers’ Deal Doesn’t Bind Congress in Health-Care Debate
Bloomberg
Saturday, August 8, 2009 - 12:34pm
tags:
Obama, healthcare reform
A Billion-Dollar Lovers' Quarrel
Motley Fool
Saturday, August 8, 2009 - 12:28pm
tags:
Elan, Biogen Idec, JNJ
Orexigen Therapeutics' 2nd-quarter loss narrows on lower expenses for obesity drug development
Yahoo/AP
Saturday, August 8, 2009 - 12:24pm
tags:
obesity, Orexigen
Genzyme's Problems Continue
Yahoo/Zacks.com
Saturday, August 8, 2009 - 12:21pm
tags:
Genzyme, Shire, Gaucher disease
Biotech Stock Mailbag: Onyx, Savient
TheStreet.com
Friday, August 7, 2009 - 11:32am
tags:
ONYX Pharmaceuticals, Savient
Warner Chilcott's profit jumps 67 percent on sales of birth control, dermatology products
Yahoo/AP
Friday, August 7, 2009 - 11:22am
tags:
Warner Chilcott, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.